Suppr超能文献

产前诊断的骶尾部畸胎瘤预后不良的预测因素:一项多机构综述。

Predictors of poor prognosis in prenatally diagnosed sacrococcygeal teratoma: A multiinstitutional review.

作者信息

Akinkuotu Adesola C, Coleman Alan, Shue Eveline, Sheikh Fariha, Hirose Shinjiro, Lim Foong-Yen, Olutoye Oluyinka O

机构信息

Texas Children's Fetal Center, Baylor College of Medicine, Houston, TX, USA; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.

Department of Pediatric Surgery, Fetal Care Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

出版信息

J Pediatr Surg. 2015 May;50(5):771-4. doi: 10.1016/j.jpedsurg.2015.02.034. Epub 2015 Feb 20.

Abstract

INTRODUCTION

Attempts at defining predictors of poor outcome in fetal sacrococcygeal teratoma (SCT) have been hampered by small patient numbers. We sought to validate the utility of tumor volume to fetal weight ratio (TFR) as a predictor of poor prognosis and to identify other morphological outcome predictors in a multicenter series.

METHODS

Records of prenatally diagnosed SCT at three fetal centers from 1986 to 2011 were reviewed. Prenatal imaging characteristics including TFR, morphology, hydrops, and placentomegaly were assessed. Poor prognosis was defined as fetal demise, need for fetal intervention, or perinatal death. Receiver operating characteristic (ROC) analysis was used to select a TFR cutoff value.

RESULTS

Seventy-nine fetuses with SCT were evaluated. Eleven pregnancies ending in elective termination were excluded. ROC analysis revealed that TFR >0.12 prior to 24 weeks gestation was predictive of poor prognosis (AUC=0.913; Sensitivity=91.7%, Specificity=76.2%, PPV=86.8%; NPV=84.2%). Solid tumor morphology and presence of hydrops were found to be predictors of poor prognosis. None of the factors associated with poor prognosis were independent predictors on multivariate analysis.

CONCLUSION

This study validates TFR >0.12 prior to 24 weeks gestation as an objective predictor of outcomes in fetuses with SCT that can be easily applied in most clinical settings.

摘要

引言

由于胎儿骶尾部畸胎瘤(SCT)患者数量较少,确定其不良预后预测因素的尝试受到了阻碍。我们试图验证肿瘤体积与胎儿体重比(TFR)作为预后不良预测指标的效用,并在一个多中心系列研究中确定其他形态学预后预测因素。

方法

回顾了1986年至2011年三个胎儿中心产前诊断SCT的记录。评估了包括TFR、形态、水肿和胎盘肿大在内的产前影像学特征。不良预后定义为胎儿死亡、需要进行胎儿干预或围产期死亡。采用受试者操作特征(ROC)分析来选择TFR临界值。

结果

对79例患有SCT的胎儿进行了评估。排除了11例以选择性终止妊娠告终的妊娠。ROC分析显示,妊娠24周前TFR>0.12可预测不良预后(AUC=0.913;敏感性=91.7%,特异性=76.2%,阳性预测值=86.8%;阴性预测值=84.2%)。实性肿瘤形态和水肿的存在被发现是不良预后的预测因素。在多变量分析中,与不良预后相关的因素均不是独立预测因素。

结论

本研究验证了妊娠24周前TFR>0.12作为SCT胎儿结局的客观预测指标,该指标可在大多数临床环境中轻松应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验